Overexpression of DNA damage-induced 45 gene contributes to esophageal squamous cell cancer by promoter hypomethylation

Journal of Experimental and Clinical Cancer Research

Volumn 31, Issue 1, 2012, Pages

  Wang, Bao Xiang ^a   Yin, Bang Liang ^a   He, Bin ^a   Chen, Chen ^a   Zhao, Ming ^a   Zhang, Wei Xing ^a   Xia, Zhen Kun ^a   Pan, Yi Zhi ^b   Tang, Jing Qun ^a   Zhou, Xin Min ^a   Yin, Ni ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

DNA damage; DNA methylation; Esophageal squamous cell cancer; GADD45

Indexed keywords

CISPLATIN; GENOMIC DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45ALPHA; LIPOFECTAMINE; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; DOWN REGULATION; DRUG SENSITIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH ARREST AND DNA DAMAGE INDUCED 45ALPHA GENE; GROWTH ARREST AND DNA DAMAGE INDUCED 45BETA GENE; GROWTH ARREST AND DNA DAMAGE INDUCED 45GAMMA GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY DEVICE; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SERUM; WESTERN BLOTTING; ESOPHAGUS TUMOR; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84862823204     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-31-11     Document Type: Article

References (49)

1. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le CM, Devarajan K, Wessels A, Soprano D, Abramowitz LK, Bartolomei MS, Rambow F, Bassi MR, Bruno T, Fanciulli M, Renner C, Klein-Szanto AJ, Matsumoto Y, Kobi D, Davidson I, Alberti C, Larue L, Bellacosa A, Cell 2011 146 1 67 79 10.1016/j.cell.2011.06.020 21722948
2. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. Kamangar F, Dores GM, Anderson WF, J Clin Oncol 2006 24 14 2137 2150 10.1200/JCO.2005.05.2308 16682732 (Pubitemid 46655601)
3. Esophageal cancer. Enzinger PC, Mayer RJ, N Engl J Med 2003 349 23 2241 2252 10.1056/NEJMra035010 14657432 (Pubitemid 37485141)
4. Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history. Morita M, Kuwano H, Ohno S, Sugimachi K, Seo Y, Tomoda H, Furusawa M, Nakashima T, Int J Cancer 1994 58 2 207 210 10.1002/ijc.2910580211 8026883 (Pubitemid 24240097)
5. Role of stress-activated MAP kinase P38 in cisplatin- and DTT-induced apoptosis of the esophageal carcinoma cell line Eca109. Zhang QX, Feng R, Zhang W, Ding Y, Yang JY, Liu GH, World J Gastroenterol 2005 11 29 4451 4456 16052670 (Pubitemid 41150381)
6. [Expression of DNA methylation of APC in peripheral blood and tumor tissue in patients with esophageal squamous cell carcinoma]. Wang CC, Mao WM, LING ZQ, Zhonghua Wei Chang Wai Ke Za Zhi 2011 14 9 719 722 21948542
7. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Lima SC, Hernandez-Vargas H, Simao T, Durand G, Kruel CD, Le Calvez-Kelm F, Ribeiro PL, Herceg Z, Epigenetics 2011 6 10 1217 1227 10.4161/epi.6.10.17199 21946330
8. Alcohol drinking, cigarette smoking, and the development of squamous cell carcinoma of the esophagus: molecular mechanisms of carcinogenesis. Toh Y, Oki E, Ohgaki K, Sakamoto Y, Ito S, Egashira A, Saeki H, Kakeji Y, Morita M, Sakaguchi Y, Okamura T, Maehara Y, Int J Clin Oncol 2010 15 2 135 44 10.1007/s10147-010-0057-6 20224883
9. Gene mutations and polymorphisms of TP53 and FHIT in chronic esophagitis and esophageal carcinoma. Silveira AP, Da SMF, Aoki S, Yamasaki LH, Rahal P, Silva AE, Anticancer Res 2011 31 5 1685 1690 21617227
10. Epigenetic silencing of MicroRNA-375 regulates PDK1 expression in esophageal cancer. Li X, Lin R, Li J, Dig Dis Sci 2011 56 10 2849 2856 10.1007/s10620-011-1711-1 21533613
11. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer. Ling ZQ, Li P, Ge MH, Zhao X, Hu FJ, Fang XH, Dong ZM, Mao WM, Int J Mol Med 2011 27 5 625 635 21373750
12. Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics. Qifeng S, Bo C, Xingtao J, Chuanliang P, Xiaogang Z, J Thorac Cardiovasc Surg 2011 141 3 808 814 10.1016/j.jtcvs.2010.04.031 21335133
13. Promoter methylation of heat shock protein B2 in human esophageal squamous cell carcinoma. Chang X, Yamashita K, Sidransky D, Kim MS, Int J Oncol 2011 38 4 1129 1135 21258768
14. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cortellino S, Xu J, Sannai M, Moore R, Caretti E, Cigliano A, Le Coz M, Devarajan K, Wessels A, Soprano D, Abramowitz LK, Bartolomei MS, Rambow F, Bassi MR, Bruno T, Fanciulli M, Renner C, Klein-Szanto AJ, Matsumoto Y, Kobi D, Davidson I, Alberti C, Larue L, Bellacosa A, Cell 2011 146 1 67 79 10.1016/j.cell.2011.06.020 21722948
15. The use of DNA polymorphisms in genetic mapping. Cullis CA, Genet Eng (N Y) 2002 24 179 189
16. Genomic instability in Gadd45a-deficient mice. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr, Nat Genet 1999 23 2 176 184 10.1038/13802 10508513 (Pubitemid 29455389)
17. Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L, Fornace AJ Jr, Cancer Res 2002 62 24 7305 7315 12499274 (Pubitemid 36025254)
18. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X, Mazzacurati L, Li X, Petrik KL, Rajasekaran B, Wu M, Zhan Q, Oncogene 2002 21 57 8696 8704 10.1038/sj.onc. 1206034 12483522 (Pubitemid 36132390)
19. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, Handa V, Doderlein G, Maltry N, Wu W, Lyko F, Niehrs C, Nature 2007 445 7128 671 675 10.1038/nature05515 17268471 (Pubitemid 46232889)
20. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Feinberg AP, Vogelstein B, Nature 1983 301 5895 89 92 10.1038/301089a0 6185846 (Pubitemid 13154475)
21. Induction of tumors in mice by genomic hypomethylation. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R, Science 2003 300 5618 489 492 10.1126/science.1083558 12702876 (Pubitemid 36444330)
22. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas. Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG, Wang F, Luo JH, Xu ZY, BMC Cancer 2009 9 9 10.1186/1471-2407-9-9 19134212
23. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. Jin S, Antinore MJ, Lung FD, Dong X, Zhao H, Fan F, Colchagie AB, Blanck P, Roller PP, Fornace AJ Jr, Zhan Q, J Biol Chem 2000 275 22 16602 16608 10.1074/jbc.M000284200 10747892 (Pubitemid 30398886)
24. Caspase-3 mediated cleavage of BRCA1 during UV-induced apoptosis. Zhan Q, Jin S, Ng B, Plisket J, Shangary S, Rathi A, Brown KD, Baskaran R, Oncogene 2002 21 34 5335 5345 10.1038/sj.onc.1205665 12149654 (Pubitemid 34948144)
25. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Salvador JM, Hollander MC, Nguyen AT, Kopp JB, Barisoni L, Moore JK, Ashwell JD, Fornace AJ Jr, Immunity 2002 16 4 499 508 10.1016/S1074-7613(02)00302-3 11970874 (Pubitemid 34442575)
26. Dimethylbenzanthracene carcinogenesis in Gadd45a-null mice is associated with decreased DNA repair and increased mutation frequency. Hollander MC, Kovalsky O, Salvador JM, Kim KE, Patterson AD, Haines DC, Fornace AJ Jr, Cancer Res 2001 61 6 2487 2491 11289119 (Pubitemid 32685828)
27. Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin. Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM, Fornace AJ Jr, Oncogene 1996 13 10 2255 2263 8950993 (Pubitemid 26411576)
28. Gadd45a functions as a promoter or suppressor of breast cancer dependent on the oncogenic stress. Tront JS, Huang Y, Fornace AJ Jr, Hoffman B, Liebermann DA, Cancer Res 2010 70 23 9671 9681 10.1158/0008-5472.CAN-10-2177 21098706
29. Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line. Zhang XY, Qu X, Wang CQ, Zhou CJ, Liu GX, Wei FC, Sun SZ, Acta Pharmacol Sin 2011 32 2 253 258 10.1038/aps.2010.208 21293478
30. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin. Carrier F, Georgel PT, Pourquier P, Blake M, Kontny HU, Antinore MJ, Gariboldi M, Myers TG, Weinstein JN, Pommier Y, Fornace AJ Jr, Mol Cell Biol 1999 19 3 1673 1685 10022855 (Pubitemid 29098226)
31. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, Carr SA, Yaffe MB, Mol Cell 2010 40 1 34 49 10.1016/j.molcel.2010.09. 018 20932473
32. Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage. Zhan Q, Mutat Res 2005 569 1-2 133 143 10.1016/j.mrfmmm.2004.06. 055 15603758 (Pubitemid 39643263)
33. Genotoxic-stress-response genes and growth-arrest genes gadd, MyD, and other genes induced by treatments eliciting growth arrest. Fornace AJ Jr, Jackman J, Hollander MC, Hoffman-Liebermann B, Liebermann DA, Ann N Y Acad Sci 1992 663 139 153 10.1111/j.1749-6632.1992.tb38657.x 1482047 (Pubitemid 23090532)
34. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Fornace AJ Jr, Nebert DW, Hollander M, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ, Mol Cell Biol 1989 9 10 4196 4203 2573827 (Pubitemid 19239587)
35. Aberrant Methylation of Different DNA Repair Genes Demonstrates Distinct Prognostic Value for Esophageal Cancer. Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM, Dig Dis Sci 2011 56 10 2992 3004 10.1007/s10620-011-1774-z 21674174
36. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Tront JS, Hoffman B, Liebermann DA, Cancer Res 2006 66 17 8448 8454 10.1158/0008-5472.CAN-06-2013 16951155 (Pubitemid 44449156)
37. DNA hypomethylation in the origin and pathogenesis of human diseases. Pogribny IP, Beland FA, Cell Mol Life Sci 2009 66 14 2249 2261 10.1007/s00018-009-0015-5 19326048
38. DNA hypomethylation and human diseases. Wilson AS, Power BE, Molloy PL, Biochim Biophys Acta 2007 1775 1 138 162 17045745 (Pubitemid 44881198)
39. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT, Cancer Epidemiol Biomarkers Prev 2007 16 1 108 114 10.1158/1055-9965.EPI-06-0636 17220338 (Pubitemid 46174272)
40. DNA methylation in thoracic neoplasms. Chen C, Yin N, Yin B, Lu Q, Cancer Lett 2011 301 1 7 16 10.1016/j.canlet.2010.10.017 21087818
41. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capella G, Ribas M, Peinado MA, Cancer Res 2006 66 17 8462 9468 10.1158/0008-5472.CAN-06-0293 16951157 (Pubitemid 44449158)
42. DNA methylation in cancer: too much, but also too little. Ehrlich M, Oncogene 2002 21 35 5400 5413 10.1038/sj.onc.1205651 12154403 (Pubitemid 34983477)
43. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Takekawa M, Saito H, Cell 1998 95 4 521 530 10.1016/S0092-8674(00)81619-0 9827804 (Pubitemid 28533308)
44. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA, Cell 1999 97 5 575 586 10.1016/S0092-8674(00)80769-2 10367887 (Pubitemid 29256961)
45. Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma. Kuwahara A, Yamamori M, Kadoyama K, Nishiguchi K, Nakamura T, Miki I, Tamura T, Okuno T, Omatsu H, Sakaeda T, J Exp Clin Cancer Res 2011 30 1 94 10.1186/1756-9966-30-94 21970688
46. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data. Koo DH, Park SI, Kim YH, Kim JH, Jung HY, Lee GH, Choi KD, Song HJ, Song HY, Shin JH, Cho KJ, Yoon DH, Kim SB, Cancer Chemother Pharmacol 2011 28 11 1750 1755 2011
47. Docetaxel plus 5-Fluorouracil and Cisplatin (DCF) Induction Chemotherapy for Locally Advanced Borderline-resectable T4 Esophageal Cancer. Yokota T, Hatooka S, Ura T, Abe T, Takahari D, Shitara K, Nomura M, Kondo C, Mizota A, Yatabe Y, Shinoda M, Muro K, Anticancer Res 2011 31 10 3535 3541 21965775
48. Weekly Taxotere and cisplatin with continuous-infusion 5-fluoruracil for the treatment of advanced gastric and esophageal cancer: a prospective, observational, single-institution experience. Piacentini P, Durante E, Trolese A, Mercanti A, Bonetti A, Gastric Cancer 2012 15 1 106 10 10.1007/s10120-011- 0078-5 21847548
49. DNA methylation and apoptosis. Gopisetty G, Ramachandran K, Singal R, Mol Immunol 2006 43 11 1729 1740 10.1016/j.molimm.2005.11.010 16500705